4.6 Editorial Material

3D Spheroids of Primary Human Hepatocytes: An In Vitro Model That Will Make Pharmacotherapy Safer?

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 109, 期 5, 页码 1186-1188

出版社

WILEY
DOI: 10.1002/cpt.2019

关键词

-

资金

  1. Personalized Medicine - Diagnostics and Therapy project from the TACR agency [TN01000013]
  2. pre-application research of innovative drugs and medical technologies project - European Union [CZ.02.1.01/0.0/0.0/18_069/001004 6]

向作者/读者索取更多资源

This study utilized 3D human hepatocyte spheroids as a model for CYP450 enzyme induction, demonstrating high sensitivity and specificity. The authors identified a noncanonical PXR-mediated CYP3A4 induction mechanism, highlighting the importance of using 3D primary human hepatocyte spheroids in preclinical induction testing.
Hendriks and coworkers(1) used 3D human hepatocytes spheroids as a novel model for CYP450 enzyme induction showing 100% sensitivity and 100% specificity when testing 12 clinically known CYP3A4 inducers. Importantly, the authors describe a noncanonical pregnane X receptor (PXR)-mediated CYP3A4 induction mechanism in the model with a compound (AZD1208), which failed in phase I clinical studies due to (auto)induction of CYP3A4 metabolism. These findings warrant the model of 3D primary human hepatocyte (PHH) spheroids in preclinical induction testing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据